Skip to content

CapEx at other companies

PTH
Pelthos Therapeutics Inc.PTHS
$194K
BridgeBio Pharma logo
BridgeBio PharmaBBIO
$69K
RFL
Rafael Holdings, Inc.RFL
$6K
Opko Health logo
Opko HealthOPK
$1.83M-42.6%
Organon logo
OrganonOGN
$37M+15.6%
Mirum Pharmaceuticals, Inc. logo
Mirum Pharmaceuticals, Inc.MIRM
$664K+1,520%

Other financials

Income statement

See full
Revenue$9.1M-22.0%
Gross profit$7.2M-30.0%
Operating income-$3.1M-342%
Net income-$3.3M-362%
EPS (diluted)-$0.22-375%

Balance sheet

See full
Cash & equivalents$11.0M-27.1%
Total debt$4.8M-7.1%
Total equity$21.6M-24.5%
Total assets$71.0M+1.5%

Cash flow

See full
Operating cash flow$387.0K-90.1%
Free cash flow$387.0K-89.9%

Valuation

See full
Market cap$97.09M+142%
Enterprise value$90.91M+212%
P/S2.3×+1.4×

Profitability

See full
Gross margin82.9%-1.4pp
Operating margin-17.2%-125pp
Net margin-17.6%-103pp
FCF margin3.3%

Returns & leverage

See full
Return on equity-29.4%-86.3pp
Debt / equity0.2×0.0×
Current ratio-0.3×

Where this comes from

Reported directly by Cumberland Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

The official record: Cumberland Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Cumberland Pharmaceuticals's capex.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Cumberland Pharmaceuticals's capex?
Cumberland Pharmaceuticals (CPIX) reported capex of $0 in Q1 2026.
How has Cumberland Pharmaceuticals's capex changed year-over-year?
Cumberland Pharmaceuticals's capex decreased by 100.0% year-over-year, from $47.63K to $0.
What is the long-term trend for Cumberland Pharmaceuticals's capex?
Over 3 years (2021 to 2025), Cumberland Pharmaceuticals's capex has grown at a -1.8% compound annual growth rate (CAGR), from $103.53K to $97.9K.
What does capex mean?
Cash spent on property, plant, and equipment — the primary measure of investment in productive capacity and infrastructure.